Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,069 JPY | -0.49% | -1.86% | +0.37% |
10:21am | Takeda Pharmaceutical Receives FDA Approval for Single-Dose Injection Crohn's Disease Treatment | MT |
Apr. 18 | Takeda Says FDA Has Approved Subcutaneous Entyvio for Crohn's Disease | DJ |
- Stock Market
- Equities
- 4502 Stock
- News Takeda Pharmaceutical Company Limited